Literature DB >> 25063869

Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood-brain barrier.

Ryan C Winger1, Jennifer E Koblinski1, Takashi Kanda2, Richard M Ransohoff3, William A Muller4.   

Abstract

Leukocyte transendothelial migration (TEM; diapedesis) is a critical event in immune surveillance and inflammation. Most TEM occurs at endothelial cell borders (paracellular). However, there is indirect evidence to suggest that, at the tight junctions of the blood-brain barrier (BBB), leukocytes migrate directly through the endothelial cell body (transcellular). Why leukocytes migrate through the endothelial cell body rather than the cell borders is unknown. To test the hypothesis that the tightness of endothelial cell junctions influences the pathway of diapedesis, we developed an in vitro model of the BBB that possessed 10-fold higher electrical resistance than standard culture conditions and strongly expressed the BBB tight junction proteins claudin-5 and claudin-3. We found that paracellular TEM was still the predominant pathway (≥98%) and TEM was dependent on PECAM-1 and CD99. We show that endothelial tight junctions expressing claudin-5 are dynamic and undergo rapid remodeling during TEM. Membrane from the endothelial lateral border recycling compartment is mobilized to the exact site of tight junction remodeling. This preserves the endothelial barrier by sealing the intercellular gaps with membrane and engaging the migrating leukocyte with unligated adhesion molecules (PECAM-1 and CD99) as it crosses the cell border. These findings provide new insights into leukocyte-endothelial interactions at the BBB and suggest that tight junctions are more dynamic than previously appreciated.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25063869      PMCID: PMC4138548          DOI: 10.4049/jimmunol.1400700

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  Migration of leukocytes across endothelial junctions: some concepts and controversies.

Authors:  W A Muller
Journal:  Microcirculation       Date:  2001-06       Impact factor: 2.628

Review 2.  Disruption of central nervous system barriers in multiple sclerosis.

Authors:  Jorge Ivan Alvarez; Romain Cayrol; Alexandre Prat
Journal:  Biochim Biophys Acta       Date:  2010-07-07

3.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

4.  A genomic comparison of in vivo and in vitro brain microvascular endothelial cells.

Authors:  Anthony R Calabria; Eric V Shusta
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-13       Impact factor: 6.200

5.  Immunopathogenesis of multiple sclerosis: new insights and therapeutic implications.

Authors:  Amer M Awad; Olaf Stüve
Journal:  Continuum (Minneap Minn)       Date:  2010-10

6.  Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains.

Authors:  Alan R Schenkel; Tina W Chew; William A Muller
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

Review 7.  Tight junctions in brain barriers during central nervous system inflammation.

Authors:  Caroline Coisne; Britta Engelhardt
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

Review 8.  Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets.

Authors:  G Z Feuerstein; X Wang; F C Barone
Journal:  Ann N Y Acad Sci       Date:  1997-10-15       Impact factor: 5.691

9.  Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1.

Authors:  F Liao; H K Huynh; A Eiroa; T Greene; E Polizzi; W A Muller
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo.

Authors:  S Bogen; J Pak; M Garifallou; X Deng; W A Muller
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  41 in total

Review 1.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

2.  HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.

Authors:  Crystal R Leibrand; Jason J Paris; Austin M Jones; Quamrun N Masuda; Matthew S Halquist; Woong-Ki Kim; Pamela E Knapp; Angela D M Kashuba; Kurt F Hauser; MaryPeace McRae
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

Review 3.  The regulation of transendothelial migration: new knowledge and new questions.

Authors:  William A Muller
Journal:  Cardiovasc Res       Date:  2015-05-17       Impact factor: 10.787

4.  Segregation of VE-cadherin from the LBRC depends on the ectodomain sequence required for homophilic adhesion.

Authors:  Gong Feng; David P Sullivan; Fei Han; William A Muller
Journal:  J Cell Sci       Date:  2015-02-01       Impact factor: 5.285

Review 5.  Viral interactions with the blood-brain barrier: old dog, new tricks.

Authors:  Jianghui Hou; Lane A Baker; Lushan Zhou; Robyn S Klein
Journal:  Tissue Barriers       Date:  2016-01-28

6.  Characterization of cell-cell junction changes associated with the formation of a strong endothelial barrier.

Authors:  MaryPeace McRae; Lindsay M LaFratta; Benjamin M Nguyen; Jason J Paris; Kurt F Hauser; Daniel E Conway
Journal:  Tissue Barriers       Date:  2018-02-01

7.  Targeted Recycling of the Lateral Border Recycling Compartment Precedes Adherens Junction Dissociation during Transendothelial Migration.

Authors:  Annette M Gonzalez; Bita F Cyrus; William A Muller
Journal:  Am J Pathol       Date:  2016-03-08       Impact factor: 4.307

8.  The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.

Authors:  Chaoling Dong; Steven P Palladino; Eric Scott Helton; Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2016-07-26       Impact factor: 17.088

9.  Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.

Authors:  Sarah E Lutz; Julian R Smith; Dae Hwan Kim; Carl V L Olson; Kyle Ellefsen; Jennifer M Bates; Sunil P Gandhi; Dritan Agalliu
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

10.  Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.

Authors:  Ryan C Winger; Christopher T Harp; Ming-Yi Chiang; David P Sullivan; Richard L Watson; Evan W Weber; Joseph R Podojil; Stephen D Miller; William A Muller
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.